<DOC>
	<DOC>NCT01356901</DOC>
	<brief_summary>The purpose of this observational study is to measure the real-life persistence, adherence and clinical effectiveness of entecavir in patients with chronic Hepatitis B viral infection.</brief_summary>
	<brief_title>Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients</brief_title>
	<detailed_description>Sampling Method: Probability Sample (consecutive patient sampling)</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>Male and female treatment na√Øve or pretreated CHB patients of at least 18 years of age Written informed consent All relevant conditions according to Summary of product characteristics (SmPC) Human immunodeficiency virus (HIV), Hepatitis C virus (HCV) or Hepatitis D virus (HDV) coinfection Patients currently included in any investigational trial on CHB</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>